To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
This broad treatment portfolio reflects the clinics emphasis on effective, personalized aesthetic care
This medication may not be suitable for people with certain conditions, so it is important to consult with a doctor if you have any health conditions
Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, says part of the problem is that many patients hope to see at least 10% body weight loss, and measure success against that bar
With features like injection site rotation, dose reminders, side effect logging, and weight tracking, Shotsy helps you stay organized throughout your GLP-1 journey
Never increase your dosage without consulting your doctor